Liver Disease Clinical Trials

Showing 661-680 of 1,279 trials

Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk

NCT05309057

Intermittent fasting is a method of restricting calories over a defined period of time and includes regimens such as whole-day fasting, alternate-day fasting, and time-restricted feeding. There is emerging evidence that intermittent fasting or energy restriction might be more beneficial than continuous energy restriction for some risk factors. The effect of intermittent fasting on risk factors associated with obesity, diabetes, and cardiovascular disease, however, is not clear. The European Association for the Study of Diabetes (EASD) has yet to make any recommendations regarding the role of intermittent fasting in the management of diabetes. To inform the update of the EASD Clinical Practice Guidelines for Nutrition Therapy, tthe Diabetes and Nutrition Study Group (DNSG) of the EASD has commissioned a systematic review and network meta-analysis of randomized controlled trials of the effect of different intermittent fasting strategies on established cardiometabolic risk factors. The findings generated by this proposed knowledge synthesis will shape guide current guidelines and improve health outcomes by educating healthcare providers and patients, and by guiding future research design.

ObesityPreDiabetesDiabetes+8 more

University of Toronto25 participantsStarted Nov 2020

Toronto, Ontario, Canada • Toronto, Ontario, Canada

UNKNOWNNA

Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression

NCT05291104

Investigate the methyl donors requirement of NAFLD patients to correct the malnutrition, lipid-toxicity, microbiota dysfunction, and metabolomics biomarkers.

Non-alcoholic Fatty Liver Disease

Fu Jen Catholic University Hospital60 participantsStarted Apr 2022

New Taipei City, Taiwan

Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk

Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression

Related Searches

Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients

High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy

Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS

To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.

Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus

Hybrid Training and Middle Age

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity

Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease

Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis

Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients

A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease

Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

Natural Course and Prognosis of Hospitalized Patients With Cirrhosis

Shear-wave Elastography Diffuse Liver Disease